Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication June 27, 2019
- Accepted for publication October 7, 2019
- Published online May 1, 2020.
Article Versions
- previous version (November 22, 2019 - 10:43).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
Author Information
- Edward O’Neill1,
- Veerle Kersemans1,
- P. Danny Allen1,
- Samantha Y.A. Terry2,
- Julia Baguña Torres1,
- Michael Mosley1,
- Sean Smart1,
- Boon Quan Lee1,
- Nadia Falzone1,
- Katherine A. Vallis1,
- Mark W. Konijnenberg3,
- Marion de Jong3,
- Julie Nonnekens3–5 and
- Bart Cornelissen1
- 1CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom
- 2Department of Imaging Chemistry and Biology, King’s College London, London, United Kingdom
- 3Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands
- 4Department of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands; and
- 5Oncode Institute, Erasmus MC, Rotterdam, The Netherlands
- For correspondence or reprints contact: Bart Cornelissen, Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building off Roosevelt Dr., Oxford OX3 7LJ, U.K. E-mail: bart.cornelissen{at}oncology.ox.ac.uk
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for 161Tb Compared with 177Lu with a Higher Dose Response for [161Tb]Tb-DOTA-LM3 Than for [161Tb]Tb-DOTATATE
- Molecular Imaging of p53 in Mouse Models of Cancer Using a Radiolabeled Antibody TAT Conjugate with SPECT
- Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
- Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-{alpha} (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors
- Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted 177Lu-DOTATATE
- Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival
- Dissimilar DNA Damage to Blood Lymphocytes After 177Lu-Labeled DOTATOC or Prostate-Specific Membrane Antigen Therapy